Monte Rosa Therapeutics Inc Stock
Monte Rosa Therapeutics Inc Stock price
Key metrics
| Market capitalization | $433.74m |
| Enterprise Value | $235.25m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| EV/Sales (TTM) EV/Sales | 15.70 |
| P/S ratio (TTM) P/S ratio | 28.95 |
| P/B ratio (TTM) P/B ratio | 2.11 |
| Revenue (TTM) Revenue | $14.98m |
| EBIT (operating result TTM) EBIT | $-128.98m |
Is Monte Rosa Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
Monte Rosa Therapeutics Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Monte Rosa Therapeutics Inc forecast:
Analyst Opinions
7 Analysts have issued a Monte Rosa Therapeutics Inc forecast:
Financial data from Monte Rosa Therapeutics Inc
| Sep '24 |
+/-
%
|
||
| Revenue | 15 15 |
-
|
|
| Gross Profit | 7.07 7.07 |
200%
200%
|
|
| EBITDA | -121 -121 |
10%
10%
|
EBIT (Operating Income) EBIT | -129 -129 |
8%
8%
|
| Net Profit | -119 -119 |
10%
10%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Monte Rosa Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Monte Rosa Therapeutics Inc Stock News
Company Profile
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
| Head office | United States |
| CEO | Markus Warmuth |
| Employees | 133 |
| Founded | 2019 |
| Website | www.monterosatx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
